Publications by authors named "Emily L Burns"
There is an increasing interest in the use of bivalirudin for pediatric extracorporeal membrane oxygenation (ECMO) anticoagulation. However, dosing is not well described in those requiring continuous renal replacement therapy (CRRT). We aimed to determine whether CRRT affects bivalirudin dosing in pediatric ECMO patients.
View Article and Find Full Text PDFArticle Synopsis
- A study was conducted to compare the effects of bivalirudin and heparin as anticoagulants in children on extracorporeal life support (ECLS) due to a lack of data on bivalirudin's use in this population.
- The review included 54 children from June 2018 to December 2019, assessing various factors like duration of support, blood product use, and survival rates.
- Results showed that bivalirudin led to longer ECLS duration but did not significantly differ in overall outcomes compared to heparin, indicating the need for larger studies to establish the best anticoagulation strategy.